Related Experiment Video
Updated: Aug 8, 2026

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
Published on: March 19, 2019
A cell surface/plasma membrane antigen of Candida albicans
1Department of Microbiology, Montana State University, Bozeman 59717.
Insights
A novel monoclonal antibody (mAb) 10G specifically targets a non-protein antigen on Candida species. This antigen is concentrated on the plasma membrane and cell wall, offering potential for diagnostic applications.
Area of Science:
- Mycology
- Immunology
- Cell Biology
Background:
- Candida albicans is a significant human pathogen.
- Understanding cell surface antigens is crucial for diagnostics and therapeutics.
- Monoclonal antibodies (mAbs) offer high specificity for antigen detection.
Purpose of the Study:
- To develop and characterize a monoclonal antibody (mAb) targeting Candida albicans.
- To determine the cellular location and nature of the recognized antigen.
- To assess the specificity of the mAb against various fungal species.
Main Methods:
- Hybridoma technology for mAb production.
- Immunoelectron microscopy (IEM) with freeze-substitution and chemical fixation.
- Treatment of cells and antigen with enzymes and heat.
- Agglutination assays with various fungal strains.
Main Results:
- mAb 10G was generated, recognizing a cell wall and plasma membrane antigen on Candida species.
- The antigen was detected on C. albicans and related species but not on other fungi.
- IEM confirmed antigen localization on the plasma membrane and cell wall.
- Surface antigen removal by beta-mercaptoethanol and Zymolyase, but not by proteases or heat, suggests a non-protein epitope.
Conclusions:
- mAb 10G identifies a specific, non-protein antigen predominantly on the plasma membrane of Candida species.
- This mAb has potential as a diagnostic tool for candidiasis.
- Further characterization of the antigen could lead to novel therapeutic strategies.
Abstract:
Antibody from BALB/cByJ mice immunized against a membranous fraction of Candida albicans agglutinated whole cells as well as the membranous fraction. Hybridoma techniques were used to isolate an IgM monoclonal antibody (mAb) designated 10G which agglutinated whole cells and reacted with the subcellular fraction. Yeast cells of 15 additional C. albicans strains and isolates of C. stellatoidea, C. tropicalis, C. intermedia and C. lusitaniae were also agglutinated by mAb 10G. The antigen was not detected on other fungi, including Candida krusei, C. utilis, Cryptococcus neoformans, Cr. albidus, Torulopsis glabrata, Rhodotorula spp. and Saccharomyces cerevisiae. To determine the cellular location of the epitope to which mAb 10G is specific, freeze-substitution was compared with traditional chemical fixation methods in preparation of samples for immunocolloidal gold electron microscopy (IEM). With both fixation procedures, the antigen recognized by mAb 10G was found randomly and densely concentrated on the plasma membrane on exponential-phase yeast-form cells and had a patchy distribution on the cell wall surface. Association of the antigen with the plasma membrane was confirmed by IEM of isolated membranes. On developing hyphal cells, antigen appeared first on the plasma membrane and later on the cell wall surface. Treatment of yeast cells with beta-mercaptoethanol and Zymolyase before fixation removed the antigen from the surface but left the cytoplasmic antigen undisturbed. Treatment of yeast cells or solubilized antigen with heat or proteolytic enzyme (trypsin, Pronase B, proteinase K) did not remove or destroy the antigen, suggesting a non-protein nature of the epitope.
Related Concept Videos
Yeast Signaling
Surface Appendages of Archaea
Fungal Phylum Ascomycota
Cryptococcal Meningitis
Candidiasis
Antifungal Agents

